ロード中...
Profile of eliglustat tartrate in the management of Gaucher disease
Gaucher disease (GD) is a lysosomal storage disorder caused by the deficient activity of acid beta glucosidase, with consequent accumulation of glucosylceramide in the spleen, liver, bone marrow, and various organs and tissues. Currently, the gold standard for GD treatment is enzyme replacement ther...
保存先:
| 出版年: | Ther Clin Risk Manag |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4714736/ https://ncbi.nlm.nih.gov/pubmed/26811686 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S73226 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|